Remolding Microenvironmental Homeostasis for Enhancing Regenerative Hypertrophic Scar Treatment Based on Functionalized Microneedles

Abstract

Hypertrophic scar (HS) is a common pathological fibrous hyperplasia with high incidence and recurrence rates. The limited understanding of the pathological characteristics of HS restricts the therapeutic efficacy of current strategies. In this study, we first identified the elevated mitophagy and suppressed apoptosis in hypertrophic scar fibroblasts (HSFs), which combined with excess inflammation to constitute the pathological microenvironment of HS, driving us to develop a functionalized microneedle (MN) patch for inhibiting mitophagy, promoting apoptosis and modulating inflammation to adapt HS treatment. The MNs integrate curcumin-loaded HSFs-derived extracellular vesicles (Cur@EV) and a decellularized extracellular matrix from umbilical cord-derived mesenchymal stem cells (UC-MSCs-dECM, UdECM). The homologous Cur@EV with enhanced cellular uptake significantly induced HSFs apoptosis via mitophagy inhibition, meanwhile reducing collagen deposition. Meanwhile, the UdECM exerted immunomodulation capacity by facilitating the M2 polarization of macrophages, aiding in the suppression of HSFs. Notably, the Cur@EV/UdECM-functionalized MN patches exhibited regenerative therapeutic outcomes on a rabbit HS model, with HS inhibition and new hair follicle formation. Overall, this study presents a synergistic strategy based on the regulation of “mitophagy-apoptosis-inflammation,” offering a novel, minimally invasive approach for HS management. The integration of homologous Cur@EV and UdECM into an MN patch represents an innovative, multifunctional approach that combines mitophagy inhibition, apoptosis induction, and immunomodulation. The regenerative outcomes observed in the rabbit HS model, including hair follicle formation, further underscore the translational potential of this strategy. Future research will focus on optimizing patch design for scalable production, assessing long-term safety and efficacy, and exploring its broader applicability.

Keywords

decellularized extracellular matrix / extracellular vesicle / hypertrophic scar / microneedle patches / targeted delivery

References

[1] V. Vorstandlechner, M. Laggner, D. Copic, et al., “The Serine Proteases Dipeptidyl-Peptidase 4 and Urokinase Are Key Molecules in Human and Mouse Scar Formation,” Nature Communications 12 (2021): 6242.

[2] B. Zhao, W. Guo, X. Zhou, et al., “Ferroptosis-Mediated Synergistic Therapy of Hypertrophic Scarring Based on Metal-Organic Framework Microneedle Patch,” Advanced Functional Materials 33 (2023): 2300575.

[3] Z. Jiang, Z. Chen, Y. Xu, et al., “Low-Frequency Ultrasound Sensitive Piezo1 Channels Regulate Keloid-Related Characteristics of Fibroblasts,” Advanced Science 11 (2024): e2305489.

[4] Z. R. Yang, H. Suo, J. W. Fan, et al., “Endogenous Stimuli-Responsive Separating Microneedles to Inhibit Hypertrophic Scar Through Remodeling the Pathological Microenvironment,” Nature Communications 15 (2024): 2038.

[5] Y. Xu, Q. Bian, Y. Zhang, et al., “Single-Dose of Integrated Bilayer Microneedles for Enhanced Hypertrophic Scar Therapy With Rapid Anti-Inflammatory and Sustained Inhibition of Myofibroblasts,” Biomaterials 312 (2025): 122742.

[6] Y. Chen, K. Chen, S. Zhong, et al., “Transdermal Transfersome Nanogels Control Hypertrophic Scar Formation via Synergy of Macrophage Phenotype-Switching and Anti-Fibrosis Effect,” Advanced Science 11 (2024): e2305468.

[7] J. Shi, S. Shi, B. Wu, et al., “Autophagy Protein LC3 Regulates the Fibrosis of Hypertrophic Scar by Controlling Bcl-xL in Dermal Fibroblasts,” Oncotarget 8 (2017): 93757-93770.

[8] J. H. Shi, D. H. Hu, Z. F. Zhang, et al., “Reduced Expression of Microtubule-Associated Protein 1 Light Chain 3 in Hypertrophic Scars,” Archives of Dermatological Research 304 (2012): 209-215.

[9] X. Deng, F. Zhao, D. Zhao, et al., “Oxymatrine Promotes Hypertrophic Scar Repair Through Reduced Human Scar Fibroblast Viability, Collagen and Induced Apoptosis via Autophagy Inhibition,” International Wound Journal 19 (2022): 1221-1231.

[10] Z. C. Wang, W. Y. Zhao, Y. Cao, et al., “The Roles of Inflammation in Keloid and Hypertrophic Scars,” Frontiers in Immunology 11 (2020): 603187.

[11] T. A. Wynn and K. M. Vannella, “Macrophages in Tissue Repair, Regeneration, and Fibrosis,” Immunity 44 (2016): 450-462.

[12] Z. Gui, X. Zhang, Q. Han, et al., “Macrophage Polarization Induces Endothelium-to-Myofibroblast Transition in Chronic Allograft Dysfunction,” Renal Failure 45 (2023): 2220418.

[13] C. Li, X. Feng, S. Li, et al., “Tetrahedral DNA Loaded siCCR2 Restrains M1 Macrophage Polarization to Ameliorate Pulmonary Fibrosis in Chemoradiation-Induced Murine Model,” Molecular Therapy 32 (2024): 766-782.

[14] H. Fei, Y. Qian, T. Pan, Y. Wei, and Y. Hu, “Curcumin Alleviates Hypertrophic Scarring by Inhibiting Fibroblast Activation and Regulating Tissue Inflammation,” Journal of Cosmetic Dermatology 23 (2024): 227-235.

[15] C. Du, Y. Tian, W. Duan, X. Chen, W. Ren, and Q. Deng, “Curcumin Enhances the Radiosensitivity of Human Urethral Scar Fibroblasts by Apoptosis, Cell Cycle Arrest and Downregulation of Smad4 via Autophagy,” Radiation Research 195 (2021): 452-462.

[16] Y. Tian, F. Zhang, Y. Qiu, et al., “Reduction of Choroidal Neovascularization via Cleavable VEGF Antibodies Conjugated to Exosomes Derived From Regulatory T Cells,” Nature Biomedical Engineering 5 (2021): 968-982.

[17] S. Zhu, H. Huang, D. Liu, S. Wen, L. Shen, and Q. Lin, “Augmented Cellular Uptake and Homologous Targeting of Exosome-Based Drug Loaded IOL for Posterior Capsular Opacification Prevention and Biosafety Improvement,” Bioactive Materials 15 (2022): 469-481.

[18] C. Wang, G. Li, K. Cui, et al., “Sulfated Glycosaminoglycans in Decellularized Placenta Matrix as Critical Regulators for Cutaneous Wound Healing,” Acta Biomaterialia 122 (2021): 199-210.

[19] S. Liu, L. Yao, Y. Wang, et al., “Immunomodulatory Hybrid Micro-Nanofiber Scaffolds Enhance Vascular Regeneration,” Bioactive Materials 21 (2023): 464-482.

[20] C. Li, B. Yi, Q. Xu, et al., “ADSCC-CM-Induced Keratin Hydrogel-Based Bioactive Microneedle Patch Containing Triamcinolone Acetonide for the Treatment of Pathological Scar,” Advanced Functional Materials 34 (2024): 2400457.

[21] S. Jiang, Y. Zhuang, M. Cai, X. Wang, and K. Lin, “Decellularized Extracellular Matrix: A Promising Strategy for Skin Repair and Regeneration,” Engineered Regeneration 4 (2023): 357-374.

[22] A. A. Golebiowska, J. T. Intravaia, V. M. Sathe, S. G. Kumbar, and S. P. Nukavarapu, “Decellularized Extracellular Matrix Biomaterials for Regenerative Therapies: Advances, Challenges and Clinical Prospects,” Bioactive Materials 32 (2024): 98-123.

[23] M. Pei, Y. A. Pei, S. Zhou, et al., “Matrix From Urine Stem Cells Boosts Tissue-Specific Stem Cell Mediated Functional Cartilage Reconstruction,” Bioactive Materials 23 (2023): 353-367.

[24] Q. Zhang, L. Shi, H. He, et al., “Down-Regulating Scar Formation by Microneedles Directly via a Mechanical Communication Pathway,” ACS Nano 16 (2022): 10163-10178.

[25] C.-C. Deng, Y.-F. Hu, D.-H. Zhu, et al., “Single-Cell RNA-Seq Reveals Fibroblast Heterogeneity and Increased Mesenchymal Fibroblasts in Human Fibrotic Skin Diseases,” Nature Communications 12 (2021): 3709.

[26] L. Galluzzi, O. Kepp, and G. Kroemer, “Mitochondria: Master Regulators of Danger Signalling,” Nature Reviews Molecular Cell Biology 13 (2012): 780-788.

[27] G. Mariño, M. Niso-Santano, E. H. Baehrecke, and G. Kroemer, “Self-Consumption: The Interplay of Autophagy and Apoptosis,” Nature Reviews Molecular Cell Biology 15 (2014): 81-94.

[28] B. Zhao, M. Wei, X. Zhou, et al., “Supramolecular Assembly-Enabled Transdermal Therapy of Hypertrophic Scarring Through Concurrent Ferroptosis-Apoptosis,” Advanced Functional Materials 35 (2025): 12.

[29] J. Wang, W. Tang, M. Yang, et al., “Inflammatory Tumor Microenvironment Responsive Neutrophil Exosomes-Based Drug Delivery System for Targeted Glioma Therapy,” Biomaterials 273 (2021): 120784.

[30] Y. Zhuang, S. Jiang, X. Deng, et al., “Energy Metabolism as Therapeutic Target for Aged Wound Repair by Engineered Extracellular Vesicle,” Science Advances 10 (2024): eadl0372.

[31] R. Schuster, F. Younesi, M. Ezzo, and B. Hinz, “The Role of Myofibroblasts in Physiological and Pathological Tissue Repair,” Cold Spring Harbor Perspectives in Biology 15 (2023): a041231.

[32] T. Kong, K. Zhang, Y. Wang, et al., “Cucumber-Derived Extracellular Vesicle-Functionalized Metal-Organic Frameworks for Enhanced Photodynamic Therapy of Hypertrophic Scars,” Advanced Functional Materials 34 (2024): 2400379.

[33] C. Mlynarczyk and R. Fåhraeus, “Endoplasmic Reticulum Stress Sensitizes Cells to DNA Damage-induced Apoptosis Through p53-dependent Suppression of p21(CDKN1A),” Nature Communications 5 (2014): 5067.

[34] A. T. Tran, M. N. Rahim, C. Ranadheera, et al., “Knockdown of Specific Host Factors Protects Against Influenza Virus-Induced Cell Death,” Cell Death & Disease 4 (2013): e769.

[35] K. Mochida, Y. Oikawa, Y. Kimura, et al., “Receptor-Mediated Selective Autophagy Degrades the Endoplasmic Reticulum and the Nucleus,” Nature 522 (2015): 359-362.

[36] S. Qian, Z. Wei, W. Yang, J. Huang, Y. Yang, and J. Wang, “The Role of BCL-2 Family Proteins in Regulating Apoptosis and Cancer Therapy,” Frontiers in Oncology 12 (2022): 985363.

[37] M. Shen, Y. Li, Y. Wang, et al., “N(6)-methyladenosine Modification Regulates Ferroptosis Through Autophagy Signaling Pathway in Hepatic Stellate Cells,” Redox Biology 47 (2021): 102151.

[38] T. Huang, T. Xu, Y. Wang, et al., “Cannabidiol Inhibits Human Glioma by Induction of Lethal Mitophagy Through Activating TRPV4,” Autophagy 17 (2021): 3592-3606.

[39] Y. Luo, X. Zeng, X. Dai, et al., “Copper Oxide Nanoparticles Impair Mouse Preimplantation Embryonic Development Through Disruption of Mitophagy-Mediated Metabolism,” ACS Nano 18 (2024): 31244-31260.

[40] S. Chawla and S. Ghosh, “Regulation of Fibrotic Changes by the Synergistic Effects of Cytokines, Dimensionality and Matrix: Towards the Development of an In Vitro Human Dermal Hypertrophic Scar Model,” Acta Biomaterialia 69 (2018): 131-145.

[41] Y. Feng, Z. L. Sun, S. Y. Liu, et al., “Direct and Indirect Roles of Macrophages in Hypertrophic Scar Formation,” Frontiers in Physiology 10 (2019): 1101.

[42] J. Chen, Y. Tang, Y. Zhong, et al., “P2Y12 Inhibitor Clopidogrel Inhibits Renal Fibrosis by Blocking Macrophage-to-Myofibroblast Transition,” Molecular Therapy 30 (2022): 3017-3033.

[43] B. S. Kim, S. Das, J. Jang, and D. W. Cho, “Decellularized Extracellular Matrix-Based Bioinks for Engineering Tissue- and Organ-Specific Microenvironments,” Chemical Reviews 120 (2020): 10608-10661.

[44] S. Lyu, Z. Dong, X. Xu, et al., “Going Below and Beyond the Surface: Microneedle Structure, Materials, Drugs, Fabrication, and Applications for Wound Healing and Tissue Regeneration,” Bioactive Materials 27 (2023): 303-326.

[45] Y. You, Y. Tian, Z. Yang, et al., “Intradermally Delivered mRNA-Encapsulating Extracellular Vesicles for Collagen-Replacement Therapy,” Nature Biomedical Engineering 7 (2023): 887-900.

[46] B. Yang, Y. Dong, Y. Shen, et al., “Bilayer Dissolving Microneedle Array Containing 5-Fluorouracil and Triamcinolone With Biphasic Release Profile for Hypertrophic Scar Therapy,” Bioactive Materials 6 (2021): 2400-2411.

[47] S. Lin, G. Quan, A. Hou, et al., “Strategy for Hypertrophic Scar Therapy: Improved Delivery of Triamcinolone Acetonide Using Mechanically Robust Tip-Concentrated Dissolving Microneedle Array,” Journal of Controlled Release 306 (2019): 69-82.

[48] D. Zhao, J. Liu, G. Liu, et al., “Ascorbyl Palmitate/Hydroxypropyl-β-cyclodextrin Inclusion Complex Loaded Nanofibrous Membrane for Accelerated Diabetic Wound Healing,” Interdisciplinary Materials 4 (2025): 175-189.

[49] L. Lei, X. Wang, Y. Zhou, et al., “Tissue and Cell Dual-Penetrating Dendritic Lipopeptide Liposomes for Hypertrophic Scar Treatment,” Advanced Functional Materials 34 (2024): 2313036.

[50] T. Wu, X. Hou, J. Li, et al., “Microneedle-Mediated Biomimetic Cyclodextrin Metal Organic Frameworks for Active Targeting and Treatment of Hypertrophic Scars,” ACS Nano 15 (2021): 20087-20104.

[51] Z. Yu, X. Meng, S. Zhang, et al., “IR-808 Loaded Nanoethosomes for Aggregation-Enhanced Synergistic Transdermal Photodynamic/Photothermal Treatment of Hypertrophic Scars,” Biomaterials Science 10 (2021): 158-166.

[52] Y. Shen, G. Xu, H. Huang, et al., “Sequential Release of Small Extracellular Vesicles From Bilayered Thiolated Alginate/Polyethylene Glycol Diacrylate Hydrogels for Scarless Wound Healing,” ACS Nano 15 (2021): 6352-6368.

[53] N. Zhang, L. Xue, A. Younas, et al., “Co-Delivery of Triamcinolone Acetonide and Verapamil for Synergistic Treatment of Hypertrophic Scars via Carboxymethyl Chitosan and Bletilla striata Polysaccharide-Based Microneedles,” Carbohydrate Polymers 284 (2022): 119219.

[54] G. G. Walmsley, Z. N. Maan, V. W. Wong, et al., “Scarless Wound Healing: Chasing the Holy Grail,” Plastic and Reconstructive Surgery 135 (2015): 907-917.

[55] S. Mascharak, H. E. desJardins-Park, M. F. Davitt, et al., “Preventing Engrailed-1 Activation in Fibroblasts Yields Wound Regeneration Without Scarring,” Science 372 (2021): eaba2374.

[56] S. Y. Chu, C. H. Chou, H. D. Huang, et al., “Mechanical Stretch Induces Hair Regeneration Through the Alternative Activation of Macrophages,” Nature Communications 10 (2019): 1524.

[57] B. Zhang and T. Chen, “Local and Systemic Mechanisms That Control the Hair Follicle Stem Cell Niche,” Nature Reviews Molecular Cell Biology 25 (2024): 87-100.

[58] X. Yang, Y. Ma, X. Wang, et al., “A 3D-Bioprinted Functional Module Based on Decellularized Extracellular Matrix Bioink for Periodontal Regeneration,” Advanced Science 10 (2023): e2205041.

RIGHTS & PERMISSIONS

2025 The Author(s). Interdisciplinary Materials published by Wuhan University of Technology and John Wiley & Sons Australia, Ltd.